Evidence map›Paper›PMID 24583195›Full record

ArticleJournal of immunological methods2014

A novel method to measure HLA-DM-susceptibility of peptides bound to MHC class II molecules based on peptide binding competition assay and differential IC(50) determination.

Liusong Yin, Lawrence J Stern

Abstract read
In one paragraph

Article in Journal of immunological methods, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.5field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Impact of HLA-DR Antigen Binding Cleft Rigidity on T Cell Recognition.International journal of molecular sciences · 2020
    Article
  3. HLA-DO Modulates the Diversity of the MHC-II Self-peptidome.Molecular & cellular proteomics : MCP · 2019
    Article
  4. Review
  5. Article
  6. Article
  7. Evaluating the Role of HLA-DM in MHC Class II-Peptide Association Reactions.Journal of immunology (Baltimore, Md. : 1950) · 2015
    Article
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Liusong YinProgram in Immunology and Microbiology, University of Massachusetts Medical School, Worcester, MA 01605, United States.
Lawrence J SternProgram in Immunology and Microbiology, University of Massachusetts Medical School, Worcester, MA 01605, United States; Department of Pathology, University of Massachusetts Medical School, Worcester, MA 01605, United States; Department of Biochemistry and Molecular Pharmacology, University of Massachusetts Medical School, Worcester, MA 01605, United States. Electronic address: Lawrence.Stern@umassmed.edu.
University of Massachusetts Chan Medical School · US

Funding

Technologies for Human Cellular ImmunologyU19AI057319 · NIAID · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI TERAJIMA, MASANORI · 2003 to 2013
$34.4M
Structure and Function of MHC ProteinsR37AI038996 · NIAID · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI STERN, LAWRENCE J. · 2008 to 2017
$4.1M
EMPTY CLASS II MHC ON DENDRITIC CELLS AND MICROGILIAR01AI048833 · NIAID · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI STERN, LAWRENCE J. · 2001 to 2012
$3.7M
Structure and Function of Class II MHC ProteinsR01AI038996 · NIAID · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI STERN, LAWRENCE J · 1996 to 2006
$1.6M
Structure and Function of Class II MHC ProteinsR56AI038996 · NIAID · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI STERN, LAWRENCE J · 2007 to 2007
$324k
NIAID NIH HHS AI-38996NIAID NIH HHS AI-57319NIAID NIH HHS R01 AI038996NIAID NIH HHS R01 AI048833NIAID NIH HHS R37 AI038996NIAID NIH HHS R56 AI038996NIAID NIH HHS U19 AI057319
6 · The paper itself

Abstract

HLA-DM (DM) functions as a peptide editor that mediates the exchange of peptides loaded onto MHCII molecules by accelerating peptide dissociation and association kinetics. The relative DM-susceptibility of peptides bound to MHCII molecules correlates with antigen presentation and immunodominance hierarchy, and measurement of DM-susceptibility has been a key effort in this field. Current assays of DM-susceptibility, based on differential peptide dissociation rates measured for individually labeled peptides over a long time base, are difficult and cumbersome. Here, we present a novel method to measure DM-susceptibility based on peptide binding competition assays performed in the presence and absence of DM, reported as a delta-IC(50) (change in 50% inhibition concentration) value. We simulated binding competition reactions of peptides with various intrinsic and DM-catalyzed kinetic parameters and found that under a wide range of conditions the delta-IC(50) value is highly correlated with DM-susceptibility as measured in off-rate assay. We confirmed experimentally that DM-susceptibility measured by delta-IC(50) is comparable to that measured by traditional off-rate assay for peptides with known DM-susceptibility hierarchy. The major advantage of this method is that it allows simple, fast and high throughput measurement of DM-susceptibility for a large set of unlabeled peptides in studies of the mechanism of DM action and for identification of CD4+ T cell epitopes.

Indexed as

Antibody AffinityAntigen PresentationBinding, CompetitiveCD4-Positive T-LymphocytesEpitopes, T-LymphocyteFluorescence PolarizationHemagglutinin Glycoproteins, Influenza VirusHistocompatibility Antigens Class IIHLA-D AntigensHLA-DR alpha-ChainsHLA-DRB1 ChainsHumansInhibitory Concentration 50Peptide FragmentsProtein BindingEpitopes, T-LymphocyteHemagglutinin Glycoproteins, Influenza VirusHistocompatibility Antigens Class IIHLA-D AntigensHLA-DM antigensHLA-DR alpha-ChainsHLA-DRB1*01:01 antigenHLA-DRB1 ChainsPeptide FragmentsBinding competitionDM-susceptibilityFluorescence polarizationIC(50)MHCII–peptide complexOff-rate

Identifiers

PMID24583195
PMCPMC4029850
OpenAlexW2042753915

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.